Literature DB >> 24323626

Treatment of stage II-III rectal cancer patients.

Miranda B Kim1, Theodore S Hong, Jennifer Y Wo.   

Abstract

The role and sequencing of radiotherapy in the management of T3-4 or node-positive rectal cancer has evolved over the last few decades. Given the significant local failure rate following surgery alone, both preoperative and postoperative chemotherapy and radiotherapy have been studied to decrease local and systemic failure and improve survival in these patients. This review discusses current indications and controversies for treatment of stage II-III rectal cancer patients.

Entities:  

Mesh:

Year:  2014        PMID: 24323626     DOI: 10.1007/s11912-013-0362-0

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  54 in total

1.  Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer.

Authors:  Robert Krempien; Falk Roeder; Susanne Oertel; Marianne Roebel; Jürgen Weitz; Frank W Hensley; Carmen Timke; Angela Funk; Marc Bischof; Angelika Zabel-Du Bois; Andreas G Niethammer; Michael J Eble; Markus W Buchler; Martina Treiber; Jürgen Debus
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-09-18       Impact factor: 7.038

2.  Improved survival with preoperative radiotherapy in resectable rectal cancer.

Authors:  B Cedermark; M Dahlberg; B Glimelius; L Påhlman; L E Rutqvist; N Wilking
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

3.  Variables correlated with the risk of lymph node metastasis in early rectal cancer.

Authors:  J T Brodsky; G K Richard; A M Cohen; B D Minsky
Journal:  Cancer       Date:  1992-01-15       Impact factor: 6.860

4.  Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

Authors:  Jean-Pierre Gérard; Thierry Conroy; Franck Bonnetain; Olivier Bouché; Olivier Chapet; Marie-Thérèse Closon-Dejardin; Michel Untereiner; Bernard Leduc; Eric Francois; Jean Maurel; Jean-François Seitz; Bruno Buecher; Rémy Mackiewicz; Michel Ducreux; Laurent Bedenne
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

5.  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Authors:  Rolf Sauer; Torsten Liersch; Susanne Merkel; Rainer Fietkau; Werner Hohenberger; Clemens Hess; Heinz Becker; Hans-Rudolf Raab; Marie-Therese Villanueva; Helmut Witzigmann; Christian Wittekind; Tim Beissbarth; Claus Rödel
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

6.  Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02.

Authors:  N Wolmark; H S Wieand; D M Hyams; L Colangelo; N V Dimitrov; E H Romond; M Wexler; D Prager; A B Cruz; P H Gordon; N J Petrelli; M Deutsch; E Mamounas; D L Wickerham; E R Fisher; H Rockette; B Fisher
Journal:  J Natl Cancer Inst       Date:  2000-03-01       Impact factor: 13.506

7.  Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.

Authors:  Mark S Roh; Linda H Colangelo; Michael J O'Connell; Greg Yothers; Melvin Deutsch; Carmen J Allegra; Morton S Kahlenberg; Luis Baez-Diaz; Carol S Ursiny; Nicholas J Petrelli; Norman Wolmark
Journal:  J Clin Oncol       Date:  2009-09-21       Impact factor: 44.544

8.  Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study.

Authors:  I Balslev; M Pedersen; P S Teglbjaerg; F Hanberg-Soerensen; J Bone; N O Jacobsen; J Overgaard; A Sell; K Bertelsen; E Hage
Journal:  Cancer       Date:  1986-07-01       Impact factor: 6.860

9.  Patterns of failure following local excision and local excision and postoperative radiation therapy for invasive rectal adenocarcinoma.

Authors:  C G Willett; J E Tepper; S Donnelly; W C Wood; P C Shellito; G V Rodkey; M A Stracher; C C Compton
Journal:  J Clin Oncol       Date:  1989-08       Impact factor: 44.544

Review 10.  Conservative treatment of rectal cancer. Extending the indications.

Authors:  R P Billingham
Journal:  Cancer       Date:  1992-09-01       Impact factor: 6.860

View more
  4 in total

1.  Impact of Intraoperative Blood Loss on the Survival of Patients With Stage II/III Colorectal Cancer: A Multicenter Retrospective Study.

Authors:  Hiroshi Tamagawa; Masakatsu Numata; Toru Aoyama; Keisuke Kazama; Yosuke Atsumi; Kenta Iguchi; Sho Sawazaki; Sumito Sato; Kazuki Kano; Takashi Ohshima; Takanobu Yamada; Teni Godai; Akio Higuchi; Hiroyuki Saeki; Norio Yukawa; Yasushi Rino
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

2.  Randomized phase III trial comparing surgery alone to UFT + PSK for stage II rectal cancer (JFMC38 trial).

Authors:  Kiyotaka Okuno; Toru Aoyama; Koji Oba; Noboru Yokoyama; Nobuhisa Matsuhashi; Katsuyuki Kunieda; Yoji Nishimura; Hiroki Akamatsu; Takaya Kobatake; Satoshi Morita; Takaki Yoshikawa; Junichi Sakamoto; Shigetoyo Saji
Journal:  Cancer Chemother Pharmacol       Date:  2017-11-01       Impact factor: 3.333

3.  Combination of carcinoembryonic antigen with the American Joint Committee on Cancer TNM staging system in rectal cancer: a real-world and large population-based study.

Authors:  Qi Liu; Peng Lian; Dakui Luo; Sanjun Cai; Qingguo Li; Xinxiang Li
Journal:  Onco Targets Ther       Date:  2018-09-13       Impact factor: 4.147

Review 4.  The value of magnetic resonance imaging to diagnose pathological complete response of rectal cancer after therapy: A protocol for meta-analysis.

Authors:  Mei Zhang; Jipin Li; Xueni Ma; Bo Wang; Jiarui Wu; Ya Gao; Jinhui Tian; Jiancheng Wang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.